Woodson Capital Management LP Buys 255,000 Shares of Establishment Labs Holdings Inc. $ESTA

Woodson Capital Management LP lifted its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 113.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 480,000 shares of the company’s stock after purchasing an additional 255,000 shares during the quarter. Establishment Labs accounts for approximately 3.6% of Woodson Capital Management LP’s holdings, making the stock its 14th biggest position. Woodson Capital Management LP owned approximately 1.66% of Establishment Labs worth $19,675,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. SG Americas Securities LLC raised its holdings in Establishment Labs by 16.0% in the third quarter. SG Americas Securities LLC now owns 10,110 shares of the company’s stock worth $414,000 after buying an additional 1,398 shares during the last quarter. Simplify Asset Management Inc. purchased a new position in Establishment Labs in the 3rd quarter worth approximately $1,555,000. Brian Low Financial Group LLC purchased a new position in Establishment Labs in the 3rd quarter worth approximately $223,000. ARS Investment Partners LLC lifted its position in Establishment Labs by 50.0% in the 3rd quarter. ARS Investment Partners LLC now owns 9,750 shares of the company’s stock valued at $400,000 after acquiring an additional 3,250 shares in the last quarter. Finally, Guided Capital Wealth Management LLC boosted its stake in Establishment Labs by 3.8% during the 3rd quarter. Guided Capital Wealth Management LLC now owns 51,650 shares of the company’s stock valued at $2,117,000 after purchasing an additional 1,908 shares during the last quarter. 72.91% of the stock is owned by hedge funds and other institutional investors.

Establishment Labs Stock Down 0.3%

ESTA opened at $65.96 on Friday. The firm’s 50 day simple moving average is $69.78 and its two-hundred day simple moving average is $52.11. The company has a market capitalization of $1.92 billion, a PE ratio of -23.23 and a beta of 0.92. Establishment Labs Holdings Inc. has a 1-year low of $26.56 and a 1-year high of $78.24. The company has a current ratio of 3.33, a quick ratio of 2.10 and a debt-to-equity ratio of 15.06.

Establishment Labs (NASDAQ:ESTA) last posted its quarterly earnings data on Wednesday, November 5th. The company reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.54) by $0.16. The firm had revenue of $53.78 million during the quarter, compared to analyst estimates of $52.28 million. Establishment Labs had a negative return on equity of 235.45% and a negative net margin of 43.45%.Establishment Labs’s revenue was up 33.8% on a year-over-year basis. During the same period in the prior year, the business posted ($0.59) EPS. As a group, equities analysts forecast that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have recently issued reports on ESTA shares. Needham & Company LLC reaffirmed a “buy” rating and set a $84.00 price target on shares of Establishment Labs in a report on Monday. Citigroup upped their target price on shares of Establishment Labs from $62.00 to $75.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. JPMorgan Chase & Co. raised their price target on shares of Establishment Labs from $71.00 to $80.00 and gave the company an “overweight” rating in a report on Wednesday, December 17th. Wall Street Zen upgraded shares of Establishment Labs from a “sell” rating to a “hold” rating in a research report on Sunday, October 19th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Establishment Labs in a report on Monday, December 29th. Six investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $78.86.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.